Oral Tetrahydrouridine-Decitabine in Patients With Advanced Myeloproliferative Neoplasms

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a phase II, multicenter, open-label study evaluating the feasibility, safety, and efficacy of oral tetrahydrouridine-decitabine (THU-decitabine) in patients with advanced myeloproliferative neoplasms (MPN).
Epistemonikos ID: d7ed591e28eaef528512b0d1bafa54c6ffc087be
First added on: Oct 15, 2026